United States · FDA National Drug Code directory
Alyglo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61476-104_7e2694c3-ad07-4724-8c50-d7eb4306b375
- Product NDC
- 61476-104
- Form
- LIQUID
- Composition / generic term
- Human immunoglobulin G
- Labeler
- GC Biopharma Corp.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20231215
- Source listing expiry
- 20271231
Source-listed ingredients
- HUMAN IMMUNOGLOBULIN G — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, GLASS in 1 CARTON (61476-104-05) / 50 mL in 1 VIAL, GLASS (61476-104-01) · 61476-104-05
- 1 VIAL, GLASS in 1 CARTON (61476-104-10) / 100 mL in 1 VIAL, GLASS (61476-104-02) · 61476-104-10
- 1 VIAL, GLASS in 1 CARTON (61476-104-20) / 200 mL in 1 VIAL, GLASS (61476-104-03) · 61476-104-20
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →